Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith D Lindor

Showing results (151-160 of 261) with videos related to

Pageof 27
Sort By:
Academic Medicine : Journal of the Association of American Medical Colleges|July 26, 2011
A model for integration of formal knowledge and clinical experience: the advanced doctoring course at Mayo Medical SchoolLiselotte N Dyrbye, Stephanie R Starr, Geoffery B Thompson, et al.
Hepatology (Baltimore, Md.)|August 25, 2021
Primary biliary cholangitis: 2021 practice guidance update from the American Association for the Study of Liver DiseasesKeith D Lindor, Christopher L Bowlus, James Boyer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 22, 2011
Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinomaEmmanouil Sinakos, Amy K Saenger, Jill Keach, et al.
Hepatology (Baltimore, Md.)|March 6, 2008
Mortality attributable to cholestatic liver disease in the United StatesFlavia D Mendes, W Ray Kim, Rachel Pedersen, et al.
Scandinavian Journal of Gastroenterology|January 19, 2016
Long-term outcomes in antimitochondrial antibody negative primary biliary cirrhosisGunnar Juliusson, Mohamad Imam, Einar S Björnsson, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 22, 2007
Open-label pilot study of folic acid in patients with nonalcoholic steatohepatitisPhunchai Charatcharoenwitthaya, Cynthia Levy, Paul Angulo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 22, 2012
Prevalence and indicators of portal hypertension in patients with nonalcoholic fatty liver diseaseFlavia D Mendes, Ayako Suzuki, Schuyler O Sanderson, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 29, 2016
An update on cancer risk and surveillance in primary sclerosing cholangitisJennifer L Horsley-Silva, Eduardo A Rodriguez, Diana L Franco, et al.
Hepatology (Baltimore, Md.)|July 9, 2004
Cost-minimization analysis of MRC versus ERCP for the diagnosis of primary sclerosing cholangitisJayant A Talwalkar, Paul Angulo, C Daniel Johnson, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|November 1, 2007
Putting the needs of the patient first: Mayo Clinic's core value, institutional culture, and professionalism covenantThomas R Viggiano, Wojciech Pawlina, Keith D Lindor, et al.
Pageof 27

Showing results (151-160 of 261) with videos related to

Sort By:
Pageof 27
Academic Medicine : Journal of the Association of American Medical Colleges|July 26, 2011
A model for integration of formal knowledge and clinical experience: the advanced doctoring course at Mayo Medical SchoolLiselotte N Dyrbye, Stephanie R Starr, Geoffery B Thompson, et al.
Hepatology (Baltimore, Md.)|August 25, 2021
Primary biliary cholangitis: 2021 practice guidance update from the American Association for the Study of Liver DiseasesKeith D Lindor, Christopher L Bowlus, James Boyer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 22, 2011
Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinomaEmmanouil Sinakos, Amy K Saenger, Jill Keach, et al.
Hepatology (Baltimore, Md.)|March 6, 2008
Mortality attributable to cholestatic liver disease in the United StatesFlavia D Mendes, W Ray Kim, Rachel Pedersen, et al.
Scandinavian Journal of Gastroenterology|January 19, 2016
Long-term outcomes in antimitochondrial antibody negative primary biliary cirrhosisGunnar Juliusson, Mohamad Imam, Einar S Björnsson, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 22, 2007
Open-label pilot study of folic acid in patients with nonalcoholic steatohepatitisPhunchai Charatcharoenwitthaya, Cynthia Levy, Paul Angulo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 22, 2012
Prevalence and indicators of portal hypertension in patients with nonalcoholic fatty liver diseaseFlavia D Mendes, Ayako Suzuki, Schuyler O Sanderson, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 29, 2016
An update on cancer risk and surveillance in primary sclerosing cholangitisJennifer L Horsley-Silva, Eduardo A Rodriguez, Diana L Franco, et al.
Hepatology (Baltimore, Md.)|July 9, 2004
Cost-minimization analysis of MRC versus ERCP for the diagnosis of primary sclerosing cholangitisJayant A Talwalkar, Paul Angulo, C Daniel Johnson, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|November 1, 2007
Putting the needs of the patient first: Mayo Clinic's core value, institutional culture, and professionalism covenantThomas R Viggiano, Wojciech Pawlina, Keith D Lindor, et al.
Pageof 27